Dulaglutide CAS:923950-08-7

Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. It helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon release, leading to improved glycemic control. Dulaglutide is administered via subcutaneous injection once weekly and is often prescribed in combination with diet and exercise to enhance diabetes management.

Order or Request Quote

Product Detail

Product Tags

Application and Effect:

Dulaglutide aids in lowering blood sugar levels after meals, reducing fasting glucose levels, and promoting weight loss. By mimicking the effects of incretin hormones, it enhances pancreatic function and insulin sensitivity, improving the body's ability to utilize glucose effectively. Additionally, Dulaglutide slows gastric emptying, helping to regulate postprandial glucose levels and decrease the risk of hypoglycemia. Aside from its glucose-lowering properties, Dulaglutide has demonstrated cardiovascular benefits by reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes at high cardiovascular risk. It has also been associated with decreased systolic blood pressure and improved lipid profiles. Dulaglutide serves as a valuable treatment option for individuals with type 2 diabetes needing additional support in managing blood sugar levels and lowering cardiovascular risk factors.